Joel Greenblatt’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
Joel Greenblatt's LXRX Position: Q3 2026 in Review
Joel Greenblatt sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 13,627 shares — an estimated $32.7K sold.
Joel Greenblatt first reported a position in LXRX in Q1 2015 and held it in 6 quarters. The position peaked at $4.24M in Q2 2016. 157 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- Joel Greenblatt reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 13,627 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $32.7K.
- Joel Greenblatt first reported a position in Lexicon Pharmaceuticals in Q1 2015 and held it in 6 quarters.
- Joel Greenblatt's Lexicon Pharmaceuticals position peaked at $4.24M in Q2 2016.
- 157 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.